Doxepin and Nightmares
Nightmares are not a commonly reported adverse effect of doxepin, and the FDA drug label does not list nightmares as a specific side effect of this medication. 1
Evidence from FDA Drug Labeling
The official FDA prescribing information for doxepin provides comprehensive adverse effect profiles but does not include nightmares in its list of CNS effects. The documented CNS side effects include:
- Drowsiness (most common)
- Confusion, disorientation, and hallucinations
- Numbness, paresthesias, ataxia
- Extrapyramidal symptoms, seizures, tardive dyskinesia, and tremor 1
Notably, while the FDA label mentions "transient visual hallucinations" as a sign of overdose, nightmares are conspicuously absent from both the therapeutic adverse effects and overdose manifestations 1.
Context from Sleep Medicine Guidelines
Clinical practice guidelines support doxepin's use specifically for sleep maintenance insomnia at low doses (3-6 mg), with the primary adverse effect being mild somnolence rather than sleep disturbances like nightmares 2, 3. The evidence shows:
- Meta-analyses demonstrated clinically significant improvements in wake after sleep onset (WASO), total sleep time (TST), and sleep efficiency
- Side effects at therapeutic doses were limited, with only mild increase in somnolence at 6 mg
- No nightmare reports emerged in the clinical trials reviewed for guideline development 2, 3
Theoretical Considerations
While research on drug-induced nightmares suggests that medications affecting norepinephrine, serotonin, and dopamine neurotransmitters can be associated with nightmare reports 4, 5, doxepin does not appear prominently in the literature on nightmare-inducing medications. The review by Pagel and Helfter (2003) examining drug-induced nightmares does not specifically implicate tricyclic antidepressants like doxepin as common culprits 4.
A 2017 review noted that some antidepressants may induce nightmares, but specifically highlighted that doxepin is classified among sedating antidepressants that "rapidly improve sleep" rather than disrupt it 6.
Clinical Bottom Line
Doxepin is unlikely to cause nightmares at therapeutic doses. If a patient on doxepin reports nightmares, consider:
- Alternative causes: Primary sleep disorders, underlying psychiatric conditions, or other medications
- Dose-related effects: Higher antidepressant doses (25-300 mg) versus low hypnotic doses (3-6 mg) may have different effect profiles
- Withdrawal phenomena: Abrupt discontinuation can cause withdrawal symptoms, though nightmares are not specifically listed 1
The sedative properties of doxepin make it more likely to suppress rather than induce disturbing dreams, particularly at the low doses used for insomnia treatment.